Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma
How Jimmy Carter’s Melanoma Diagnosis Introduced Immunotherapy to Cancer Care
FDA Announces Priority Review for CUTX-101 to Treat Menkes Disease
IVIG Supplementation Reduces Infection Risk in Patients With Multiple Myeloma Receiving Teclistamab